NASDAQ:MDAS (MDAS) (MDAS) Stock Price, News & Analysis → Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad) Free MDAS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$31.35▼$31.3550-Day Range N/A52-Week Range$17.00▼$31.35VolumeN/AAverage Volume1.79 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (MDAS) alerts: Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> About (MDAS) Stock (NASDAQ:MDAS)MedAssets, Inc. (MedAssets) provides technology-enabled products and services to healthcare organizations, including hospitals, health systems, non-acute healthcare providers, payers, other service providers and product manufacturers. The Company operates its business through two business segments: Spend and Clinical Resource Management (SCM) and Revenue Cycle Management (RCM). The SCM segment delivers market insight, performance improvement advisory and cost management capabilities to healthcare providers. The RCM segment provides revenue cycle management solutions to healthcare providers, primarily hospitals and health systems. The Company’s technology-enabled solutions are delivered through the Company-hosted software or software as a service (SaaS) or Web-based applications. Its Web-based applications employ cloud computing by using the Internet to deploy the Company’s solutions across decentralized health care organizations, providing standardization and compliance.Read More Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> MDAS Stock News HeadlinesApril 17, 2024 | msn.comNigeria: Tenure Policy - NUC Management 'Ignores' Director's Retirement NoticeApril 16, 2024 | msn.comGovt to pay Shs7.5t in harmonised wage billApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.April 16, 2024 | baystreet.caOcean Power Technology Loses Ground on NewsApril 13, 2024 | msn.comFG reveals revenue received from MDAs in FebruaryApril 12, 2024 | msn.comMDAs remitted N835.7bn revenue to FG in February – EdunApril 11, 2024 | msn.comBanks face Sh500bn hit on State’s single account shiftApril 10, 2024 | msn.comTech-aided assessment: Tracker app empowers Nigerians to monitor ministers’ performancesApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.April 10, 2024 | msn.comAig-Imoukhuede Foundation trains civil servants in leadershipApril 8, 2024 | msn.comFG’s policy thrust will birth $1trn economy for Nigeria — IMPIApril 8, 2024 | msn.comFG Sets Up Committee To Promote Health Of Civil ServantsApril 8, 2024 | msn.comCountdown to ending era of commercial banks holding Kenyan taxpayers’ moneyApril 8, 2024 | msn.comSolar eclipse 2024: Where to watch rare celestial event in Bay Area todayApril 5, 2024 | msn.comDon't Overrun Budgets for Projects - Finance Minister Appeals to MDAsApril 2, 2024 | msn.comOndo AG Ajulo unfolds eight-point reformsApril 2, 2024 | msn.comNGO’s lament spate of insecurities in KogiApril 2, 2024 | msn.comMWAURA: How KK administration is planning to spur economic take-offApril 1, 2024 | msn.comTreasury Looting and Questions Over Tinubu's Anti-Graft Drive [editorial]March 31, 2024 | msn.comTSA: REMITA Was Selected Based On Merit — CBNMarch 31, 2024 | msn.comUganda out to solve animal feeds puzzleMarch 29, 2024 | msn.comRemita's Choice As Payment Facilitator Merit-Based - CBNMarch 27, 2024 | msn.comNine out of 31 Cross River MDAs cleared for March salaries – HoS, EtengMarch 26, 2024 | msn.com22 out of 31 MDAs won’t receive March salaries – C’River Head of Service, EtengMarch 26, 2024 | msn.comGovt employees to undergo weekly physical exercisesMarch 22, 2024 | msn.comMDAs to get incentives to attract health workers – Acting Chief DirectorMarch 22, 2024 | msn.comNASS oversights promote transparency, accountability in MDAs – MinisterSee More Headlines Receive MDAS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (MDAS) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings7/29/2015Today4/19/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryHealth Care Technology Current SymbolNASDAQ:MDAS CUSIP58404510 CIK1254419 Webwww.medassets.com Phone+1-678-3232500FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report MDAS Stock Analysis - Frequently Asked Questions How were (MDAS)'s earnings last quarter? (MDAS) (NASDAQ:MDAS) issued its quarterly earnings data on Wednesday, July, 29th. The technology company reported $0.31 earnings per share for the quarter, topping analysts' consensus estimates of $0.27 by $0.04. The technology company earned $190.40 million during the quarter, compared to analyst estimates of $187.45 million. The company's revenue was up 8.6% on a year-over-year basis. During the same quarter last year, the company posted $0.30 EPS. What other stocks do shareholders of (MDAS) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (MDAS) investors own include CVS Health (CVS), Home Depot (HD), StoneMor (STON), Blackstone (BX), NVIDIA (NVDA), AbbVie (ABBV), Broadcom (AVGO), Cadence Design Systems (CDNS), DexCom (DXCM) and The Goldman Sachs Group (GS). This page (NASDAQ:MDAS) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving TrendsUrgent alert: open this for a huge profit potentialTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (MDAS) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.